Proteasome activity was decreased in the <i>myc-rpt6-S119A</i> mutant. by Esther Magdalena Marquez-Lona (4183126)

“…The mean ± SEM rate of Suc-LLVY-AMC cleavage is decreased in the <i>myc-rpt6-S119A</i> mutant compared to the WT and <i>myc-rpt6-S119D</i> strains. …”

The decrease in blood flow disrupts CV pruning. by Lin Wen (557398)

Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%. by Joseph Kamgno (81039)

“…<p>Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.…”

Expression of ApoB-50 decreased lipid accumulation and inhibited HCV production. by Bei Wang (116772)

A Knockout Mutation of a Constitutive GPCR in <em>Tetrahymena</em> Decreases Both G-Protein Activity and Chemoattraction by Thomas J. Lampert (194549)

“…Since the basal G-protein activity is decreased by the GPCR6 knockout, it is likely that this gene codes for a constitutively active GPCR in <em>Tetrahymena</em>. …”

KDM6A mRNA expression is decreased in PTFE mice. by Simon Lebek (9756148)

Subjects:

Damsin (D) and ambrosin (A) treatment decreases the CSC population. by Wendy Soria Sotillo (4408105)

SAHA Decreases HDAC 2 and 4 Levels <em>In Vivo</em> and Improves Molecular Phenotypes in the R6/2 Mouse Model of Huntington's Disease by Michal Mielcarek (195209)

“…Consistent with our previous data, SAHA treatment diminishes <em>Hdac7</em> transcript levels in both wild type and R6/2 brains and unexpectedly was found to decrease <em>Hdac11</em> in R6/2 but not wild type. …”

Comparison of the decrease of CFU in CSF and blood between treatment groups within the first 6 h after treatment. by Luca G. Valente (12463057)

Decreased oscillatory flow decreases <i>klf2a</i> expression. by Julien Vermot (257990)

“…(L) Quantitative RT-PCR showing the expression level of several flow-responsive genes after lidocaine treatment. <i>klf2a</i> expression is significantly decreased after 6 and 10 h of treatment and is restored by incubation at 34°C; 100% of expression corresponds to a normal expression level. …”

SDG decreases p70S6K1 and increases AMPK protein expression in iron treated H9c2 cells. by Stephanie Puukila (568109)

MPLA decreases immunogenicity of 6OXY-TT vaccine. by Marco Pravetoni (491897)

DMB treatment decreased neuronal apoptosis in cerebral ischemia. by Huinan Zhang (849524)

FTY720 treatment decreased tumor growth in a xenograft model of hepatoblastoma. by Laura L. Stafman (6577184)

Subjects:

Swimming and swarming motility phenotypes of single gene deletion mutants putatively decreasing motility. by Julia Andrea Deditius (782678)

Unique Biofilm Signature, Drug Susceptibility and Decreased Virulence in <em>Drosophila</em> through the <em>Pseudomonas aeruginosa</em> Two-Component System PprAB by Sophie de Bentzmann (116508)

“…Here we decipher the regulon of the <em>P. aeruginosa</em> response regulator PprB of the TCS PprAB. …”

Loss of Prox1a decreases PR production at 120 hours post-ablation. by Kellie Veen (17343374)

Ectopic lesions are decreased in PUGKO mice compared to controls. by Jan Sunde (8837384)

“…Oviduct tissue and endometrium from progesterone treated (PUGKO) and vehicle control donor mice were collected and processed, then injected into WT C57Bl/6J recipient mice. Due to the fluorescent nature of the tdT mouse tissue, all tissue that implanted in the recipient mice could be identified using a red filter with a green light exposure. …”

FTY720 decreased viability, proliferation, and motility and induced apoptosis in human hepatoblastoma cells. by Laura L. Stafman (6577184)

Subjects:

Imatinib decreases <i>in vivo</i> proliferation of T-cells. by Ludovic Belle (293091)